D

Anika Therapeutics, Inc. ANIK

$13.62 $0.775.99% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$12.76$13.84
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

ANIK Rating

Reward
Risk

ANIK Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ANIK Company Overview

Anika Therapeutics, Inc. is a U.S.-based biotechnology and medical technology company focused on developing, manufacturing, and commercializing products primarily for orthopedic care, osteoarthritis pain management, regenerative solutions, and sports medicine applications. The company operates within the broader musculoskeletal healthcare and orthopedic device industries, with a business model centered on proprietary hyaluronic acid (HA) technologies and regenerative medicine platforms. Its core revenue drivers historically have included viscosupplementation products for osteoarthritis of the knee, orthopedic regenerative products, and sports medicine and joint preservation solutions used by physicians, ambulatory surgery centers, and hospitals.

Anika was founded in 1983 and is headquartered in Massachusetts, United States. The company initially built its business around HA-based products used in osteoarthritis treatment and later expanded through internal product development and acquisitions into regenerative solutions and minimally invasive orthopedic repair technologies. Over time, Anika evolved from a single-product viscosupplementation company into a diversified orthopedic-focused organization with offerings spanning pain management, tissue preservation, and surgical repair technologies. Its strategic positioning is supported by long-standing expertise in HA chemistry, manufacturing capabilities, and relationships within orthopedic and sports medicine markets.

Data compiled by narrative technology. May contain errors.
Sector

ANIK Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ANIK Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ANIK Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ANIK Price History

Loading...
52-Week Range33% of range
Current
$13.62
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ANIK Valuation

Market Cap
Market Cap Rank
#10,053
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ANIK Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

ANIK Corporate Info

Phone Number
781 457 9000
Address
32 Wiggins Avenue
Bedford, MA 01730
Country
Year Founded

ANIK Filings

Filing Date
Friday, November 6, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Mar 1 and 5 (est)

ANIK Headlines